More Shots on Goal: Heterologous Influenza Prime-Boost Vaccination Decreases the Likelihood of a Negligible Antibody Response to Current or Historical Variants
Seasonal influenza vaccination only elicits a strong and durable antibody response in a subset of recipients, and prior homologous booster trials have fail